These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 30053293)
1. Protection against duck hepatitis a virus type 1 conferred by a recombinant avian adeno-associated virus. Wang AP; Liu L; Gu LL; Guo CM; Wu S; Feng Q; Xia WL; Wu Z; Zhu SY Poult Sci; 2019 Jan; 98(1):112-118. PubMed ID: 30053293 [TBL] [Abstract][Full Text] [Related]
2. Expression of duck hepatitis A virus type 1 VP3 protein mediated by avian adeno-associated virus and its immunogenicity in ducklings. Wang AP; Liu L; Gu LL; Wu S; Guo CM; Feng Q; Xia WL; Yuan C; Zhu SY Acta Virol; 2019; 63(1):53-59. PubMed ID: 30879313 [TBL] [Abstract][Full Text] [Related]
3. Recombinant VP1 protein of duck hepatitis virus 1 expressed in Pichia pastoris and its immunogenicity in ducks. Wang C; Li XK; Wu TC; Wang Y; Zhang CJ; Cheng XC; Chen PY Acta Virol; 2014; 58(4):333-9. PubMed ID: 25518714 [TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings. Kang M; Roh JH; Jang HK Vet Microbiol; 2018 Feb; 214():108-112. PubMed ID: 29408021 [TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of duck hepatitis A virus type 3 and innate immune responses of the ducklings to virulent DHAV-3. Zhang X; Cao C; Qu Z; Zhang W; Liu Y; Qi H; Hao C; Zhang W; Gao M; Wang J; Ma B Mol Immunol; 2018 Mar; 95():30-38. PubMed ID: 29407574 [TBL] [Abstract][Full Text] [Related]
6. Protective immune responses in ducklings induced by a suicidal DNA vaccine of the VP1 gene of duck hepatitis virus type 1. Fu Y; Chen Z; Li C; Liu G Vet Microbiol; 2012 Dec; 160(3-4):314-8. PubMed ID: 22819169 [TBL] [Abstract][Full Text] [Related]
7. Efficient production of an avian adeno-associated virus vector using insect cell/baculovirus expression system. Wang A; Wang Y; Wu S; Zuo W; Guo C; Hong W; Zhu S J Virol Methods; 2017 Feb; 240():26-31. PubMed ID: 27867046 [TBL] [Abstract][Full Text] [Related]
8. [Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis]. Yin F; Jing L; Zhang S; Yu M; Zhang W; Fan G; Dong X; Liu W Sheng Wu Gong Cheng Xue Bao; 2015 Nov; 31(11):1579-88. PubMed ID: 26939441 [TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015. Wen X; Zhu D; Cheng A; Wang M; Chen S; Jia R; Liu M; Sun K; Zhao X; Yang Q; Wu Y; Chen X Transbound Emerg Dis; 2018 Feb; 65(1):10-15. PubMed ID: 29076646 [TBL] [Abstract][Full Text] [Related]
10. Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections. Kim MC; Kim MJ; Kwon YK; Lindberg AM; Joh SJ; Kwon HM; Lee YJ; Kwon JH Vaccine; 2009 Nov; 27(48):6688-94. PubMed ID: 19747575 [TBL] [Abstract][Full Text] [Related]
11. Study on the expression of human lysozyme in oviduct bioreactor mediated by recombinant avian adeno-associated virus. Wang AP; Wang YJ; Wu S; Zuo WY; Guo CM; Hong WM; Zhu SY Poult Sci; 2017 Jul; 96(7):2447-2453. PubMed ID: 28339926 [TBL] [Abstract][Full Text] [Related]
12. [Indirect ELISA for simultaneous detection of antibodies against duck hepatitis A type 1 and 3 viruses]. Zhang Y; Ma X; Huang B; Li Y; Yu K; Li J; Liu C; Han H; Cui Y Wei Sheng Wu Xue Bao; 2015 Apr; 55(4):501-9. PubMed ID: 26211325 [TBL] [Abstract][Full Text] [Related]
13. Identification of a conserved neutralizing linear B-cell epitope in the VP1 proteins of duck hepatitis A virus type 1 and 3. Zhang R; Zhou G; Xin Y; Chen J; Lin S; Tian Y; Xie Z; Jiang S Vet Microbiol; 2015 Nov; 180(3-4):196-204. PubMed ID: 26427545 [TBL] [Abstract][Full Text] [Related]
14. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine. Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463 [TBL] [Abstract][Full Text] [Related]
15. [Inhibition of infectious bursal disease virus replication in chicken embryos by miRNAs delivered by recombinant avian adeno-associated viral vector]. Shen P; Wang Y; Sun H; Zhang X; Xia X Wei Sheng Wu Xue Bao; 2011 Feb; 51(2):256-61. PubMed ID: 21574388 [TBL] [Abstract][Full Text] [Related]
16. Development of the first officially licensed live attenuated duck hepatitis A virus type 3 vaccine strain HB80 in China and its protective efficacy against DHAV-3 infection in ducks. Fu Q; Han X; Zhu C; Jiao W; Liu R; Feng Z; Huang Y; Chen Z; Wan C; Lai Z; Liang Q; Shi S; Cheng L; Chen H; Jiang N; Su J; Fu G; Huang Y Poult Sci; 2024 Oct; 103(10):104087. PubMed ID: 39094497 [TBL] [Abstract][Full Text] [Related]
17. Evidence of possible vertical transmission of duck hepatitis A virus type 1 in ducks. Zhang R; Yang Y; Lan J; Xie Z; Zhang X; Jiang S Transbound Emerg Dis; 2021 Mar; 68(2):267-275. PubMed ID: 32598568 [TBL] [Abstract][Full Text] [Related]
18. First Report of Duck Hepatitis A Virus 3 from Duckling Flocks of Egypt. Hassan TIR; Eid AAM; Ghanem IAI; Shahin AM; Adael SAA; Mohamed FF Avian Dis; 2020 Sep; 64(3):269-276. PubMed ID: 33205161 [TBL] [Abstract][Full Text] [Related]
19. Dual Circulation of Duck Hepatitis A Virus Genotypes 1 and 3 in Egypt. Yehia N; Erfan AM; Omar SE; Soliman MA Avian Dis; 2021 Mar; 65(1):1-9. PubMed ID: 34339115 [TBL] [Abstract][Full Text] [Related]
20. Detection, differentiation, and VP1 sequencing of duck hepatitis A virus type 1 and type 3 by a 1-step duplex reverse-transcription PCR assay. Wen XJ; Cheng AC; Wang MS; Jia RY; Zhu DK; Chen S; Liu MF; Liu F; Chen XY Poult Sci; 2014 Sep; 93(9):2184-92. PubMed ID: 25012848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]